Betahistine
- Generic Name
- Betahistine
- Brand Names
- Serc
- Drug Type
- Small Molecule
- Chemical Formula
- C8H12N2
- CAS Number
- 5638-76-6
- Unique Ingredient Identifier
- X32KK4201D
- Background
Ménière's disease is a progressive disease of the inner ear characterized by vertigo, tinnitus, and hearing loss. It has a significant impact on both the physical and social functioning of affected individuals.
...
- Indication
Betahistine is indicated for the reduction of recurrent vertigo episodes associated with Ménière's disease in patients 18 years old and above.
- Associated Conditions
- Menière's Disease
- Associated Therapies
- -
The Effect of Betahistine on Body Weight in Obese Subjects
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- OBEcure Ltd.
- Target Recruit Count
- 280
- Registration Number
- NCT00409305
- Locations
- 🇺🇸
Scripps Clinic, Nutrition Metabolic Research, San Diego, California, United States
🇺🇸Rochester Clinical Research, Inc., Rochester, New York, United States
🇺🇸Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath